News & Press Releases

Law360 featured the arrival of seasoned U.S. International Trade Commission attorney Jonathan Engler as a Member of Mintz’s Intellectual Property Practice in Washington, D.C. The article included commentary from Mr. Engler on what attracted him to Mintz and areas of focus within his practice, and also included a quote from Mintz Member and Chair of the firm’s Intellectual Property Division Michael Renaud.

Mintz advised Cardurion Pharmaceuticals, Inc., a biotechnology company developing novel therapeutics to treat heart failure and other cardiovascular diseases, in a private investment of up to $300 million from Bain Capital Life Sciences and Bain Capital Private Equity that will enable the Boston-based company to expand its drug discovery programs.

Mintz Of Counsel Kate Stewart was quoted in an edition of HCPro’s “Briefings on HIPAA” regarding policy and procedure considerations for HIPAA compliance officers with the Office of the National Coordinator for Health Information Technology (ONC)’s 21st Century Cures Act: Interoperability, Information Blocking, and the ONC Health IT Certification Program in effect.

In an article published by Bloomberg Law, Mintz Member Andrew Skale commented on a trademark infringement lawsuit brought by a local roller derby team against Major League Baseball's Cleveland Indians in advance of the Indians’ anticipated name change to the Guardians. Mr. Skale joined other intellectual property and trademark attorneys in suggesting that a settlement would be in both parties’ interests.

Mintz Member Andrew Skale was among trademark lawyers to provide insights for a Reuters article on a trademark infringement lawsuit brought by a local roller derby team against Major League Baseball's Cleveland Indians in advance of the Indians’ anticipated name change to the Guardians.